| Product Code: ETC9966843 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Gene Therapy Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Gene Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Gene Therapy Market - Industry Life Cycle |
3.4 United States (US) Gene Therapy Market - Porter's Five Forces |
3.5 United States (US) Gene Therapy Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Gene Therapy Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 United States (US) Gene Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders and chronic diseases in the US |
4.2.2 Growing investments in research and development of gene therapy technologies |
4.2.3 Favorable regulatory environment supporting gene therapy advancements |
4.3 Market Restraints |
4.3.1 High cost associated with gene therapy treatments |
4.3.2 Limited awareness and understanding of gene therapy among patients and healthcare professionals |
4.3.3 Challenges related to the delivery and administration of gene therapy products |
5 United States (US) Gene Therapy Market Trends |
6 United States (US) Gene Therapy Market, By Types |
6.1 United States (US) Gene Therapy Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Gene Therapy Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Gene Therapy Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 United States (US) Gene Therapy Market Revenues & Volume, By Media, 2021- 2031F |
6.1.5 United States (US) Gene Therapy Market Revenues & Volume, By Sera, 2021- 2031F |
6.1.6 United States (US) Gene Therapy Market Revenues & Volume, By Reagents, 2021- 2031F |
6.2 United States (US) Gene Therapy Market, By End-User |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Gene Therapy Market Revenues & Volume, By Biotechnology Companies, 2021- 2031F |
6.2.3 United States (US) Gene Therapy Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.2.4 United States (US) Gene Therapy Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
6.2.5 United States (US) Gene Therapy Market Revenues & Volume, By Research Institutes, 2021- 2031F |
7 United States (US) Gene Therapy Market Import-Export Trade Statistics |
7.1 United States (US) Gene Therapy Market Export to Major Countries |
7.2 United States (US) Gene Therapy Market Imports from Major Countries |
8 United States (US) Gene Therapy Market Key Performance Indicators |
8.1 Number of clinical trials and research studies related to gene therapy in the US |
8.2 Adoption rate of gene therapy treatments in different therapeutic areas |
8.3 Number of partnerships and collaborations between biopharmaceutical companies and research institutions for gene therapy development |
9 United States (US) Gene Therapy Market - Opportunity Assessment |
9.1 United States (US) Gene Therapy Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Gene Therapy Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 United States (US) Gene Therapy Market - Competitive Landscape |
10.1 United States (US) Gene Therapy Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Gene Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here